Archives: January 2018

Jason Hope Helps Aid the Future of Medicine by Supporting the SENS Foundation

Jason Hope has been described as someone who always looks toward the future. This forward moving attitude can be seen in the organizations he chooses to support through his charitable contributions. Most recently, this successful Internet business entrepreneur pledged 500,000 dollars to the SENS Foundation to aid their anti-aging research. This foundation focuses their efforts on rejuvenation research, which holds the possibility of eliminating many of the conditions associated with old age, including Alzheimer’s. Jason Hope wholly supports the work being done by the Foundation’s lead physician, Dr. Aubrey de Grey.

When looking at the areas of business Jason Hope is passionate about, the half a million dollar pledge he made to the SENS Foundation makes perfect sense. Currently residing in Scottsdale, Arizona Jason Hope has always had a passion for technology. He began his career in business by attending Arizona State University from which he obtained his finance degree. He then went on to earn his MBA from the W.P. Carey Business School. Although he started out by creating his own mobile communications business, he now focuses his efforts on backing projects in biotechnology as well as investing in startups.

Jason Hope sees himself as an integral part of the future of humankind. His insights into the world of technology have helped him gain a perspective on where the future of medicine is headed. In this respect, he believes the work being conducted at the SENS Foundation is definitely worth investing in. Not only does he see the work this Foundation does as being a necessary step in the evolution of modern medicine, but he also believes there should be a new branch of medicine devoted entirely to the biotech industry. This would allow for more changes to be made toward the process of medicine as it relates to all fields of health.

Jason Hope’s philanthropic steps toward helping the SENS Foundation are not the only charitable endeavors he has made. When looking to assist startup companies in the world of business, he looks for people who have amazing ideas and assists them with grants that help them put those ideas into action. In his personal approach to business he tries to keep his ideas simple to maintain a higher degree of success. Since most of what he does involves the Internet he has often described futuristic trends as being related to IoT or the Internet of Things, which he is excited to see continue to evolve in the future.

Jason Hope’s Facebook Page: www.facebook.com/jason.r.hope

Why Sahm Adrangi is One of the Most Influential Hedge Funders

Sahm Adrangi is a hedge funder who is primarily known for short selling and publishing research. In 2009 the businessman and entrepreneur founded Kerrisdale Capital Management, a research oriented investment firm. He also serves as the firm’s Chief Investment Officer. Overall, as founder and CIO Adrangi is takes a very hands on approach to running the firm. He is heavily involved in every major decision and direction of the firm’s development. Under the leadership of Adrangi the firm has grown form a company founded with less than $1 million to one that now manages more than $150 million.

Early in his career Sahm Adrangi garnered attention by exposing Chinese companies for shady business practices. Some of the more notable companies he exposed include China Marine Food Group and Lihua International. Because of Adrangi’s efforts many of these companies were targeted by the Securities and Exchange Commission.

Although Sahm Adrangi and Kerrisdale Capital do not discriminate against which companies they research the hedge funder has made companies in the biotech industry an important area of focus lately. This could be because Kerrisdale recently developed an expertise in the biotech sector. He has called out several companies for fraudulent behavior and is usually right.

Sahm Adrangi recently led a brutal attack against biotech company Prothena. He blasted the company by strongly predicting its lead drug would be a failure. The drug in question was NEOD001, an AL amyloidosis drug. And as usual he was spot on. The drug underperformed in trials and was written off by Prothena.

One things for sure is that Adrangi takes no prisoners. When he sets his sights on a target he is both brutal and relentless. He single-handedly has every comapny in the biotech sector on their Ps and Qs. This is why he is one of the most influential hi=edge funders in the nation.

His Twitter Profile: https://twitter.com/sahmadrangi